Massivemarkets

Nasdaq: BLSM · Listed Aug 7, 2026

BlossomHill Therapeutics Inc.. IPO

IPO price

$16.00

BlossomHill Therapeutics Inc.. (BLSM) priced its IPO at $16.00 a share and has traded on Nasdaq since Aug 7, 2026.

BLSM today$14.59-8.81%since IPO15-min delayed · as of 4:40:11 PM EST on Nov 18, 2026

See the BLSM quote

First trading day · Aug 7, 2026

IPO price 16.00VWAP 15.76first trade 15.75-1.56% from the IPO pricehigh 16.00low 15.26$16.00volume · rising bars above the line, falling bars below169.27K12:304:00
IPO price
$16.00
inside the range of $15 to $17
First trade
$15.75
-1.56% from the IPO price
First-day last trade
$16.00
+0.00% from the IPO price, regular session
Raise
$150M
before the underwriters' option

These numbers are from the first trading day, Aug 7, 2026.

How BLSM did against the market

BLSM against the market, from its first trade at 12:30 ET to the last trade of the session.

BLSM from its first trade
+1.59%
Against the market (QQQ)
+1.2 pts

BLSM rose 1.6% from its first trade to the last trade of the session. That is 1.2 points better than the market.

Same-day moves do not show that BLSM caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

BLSM against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+50%+100%+150%+200%+250%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%BLSM +60.69%

The IPO scoreboard

BLSM against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

BLSM against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
BlossomHill Therapeutics Inc.. '26$150M-1.56%+0.00%+2.12%+60.69%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The BlossomHill Therapeutics Inc.. IPO offers 9.38M shares to raise $150M, before any underwriters' option.

$13$15$16$17$19
Expected price range
$15 to $17
IPO price
$16.00
Shares offered
9.38M
Money raised
$150M
Listing date
Aug 7, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • BlossomHill Therapeutics Inc..$150M

Where BLSM ranks

BlossomHill Therapeutics Inc..'s market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • BLSM$463.74M

Filings and the company

What BlossomHill Therapeutics Inc.. has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that BlossomHill Therapeutics Inc.. discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • Quarterly earningsSep 18, 2026

    On September 18, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.

  • On September 15, 2026, BlossomHill Therapeutics, Inc. issued a press release announcing updated data from the ongoing Phase 1/2 SOLARA trial of BH-30643 in non-small cell lung cancer (NSCLC) patients with secondary epidermal growth factor receptor (EGFR) resistance mutations such as EGFR C797S.

  • Public offeringAug 10, 2026

    On August 10, 2026, the Company completed its IPO of an aggregate of 9,375,000 shares of common stock at a price to the public of $16.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $150.0 million.

About BlossomHill Therapeutics Inc..

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.

Ticker
BLSM
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
PHARMACEUTICAL PREPARATIONS
Employees
71
Listed
Aug 7, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the BlossomHill Therapeutics Inc.. IPO price?

$16.00 a share.

When did BlossomHill Therapeutics Inc.. go public?

BlossomHill Therapeutics Inc.. listed on Nasdaq on Aug 7, 2026 under the ticker BLSM.

How much did the BlossomHill Therapeutics Inc.. IPO raise?

$150M, before any underwriters' option.

How did BlossomHill Therapeutics Inc.. open on its first day?

BLSM first traded at $15.75, -1.56% from the IPO price of $16.00.

How did BLSM close on its first day?

Its last regular-session trade was $16.00, +0.00% from the IPO price of $16.00.

What was the BLSM first-day trading range?

$15.25 to $16.05 in the regular session.

How many BLSM shares traded on the first day?

1.67M shares in the regular session.

How many shares did BlossomHill Therapeutics Inc.. sell in its IPO?

9.38M shares.

How did BLSM do against the market on its first day?

BLSM rose 1.6% from its first trade to the last trade of the session. That is 1.2 points better than the market (QQQ, the Nasdaq-100 ETF).

What exchange is BLSM listed on?

BlossomHill Therapeutics Inc.. lists on Nasdaq under the ticker BLSM.

Build with Massive

Get the BLSM data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/BLSM/range/5/minute
Market cap/v3/reference/tickers/BLSM
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.